Dr. Schoske serves as Chief, Diagnostics, and Detection Division for the Defense Threat Reduction Agency (DTRA), Research and Development Directorate, Chemical Biological Technologies Department (RD-CB). In this capacity Dr. Schoske overseas and manages an $90 million Research and Development Portfolio. This portfolio includes projects in the areas of medical diagnostics, and chemical and biological agent detection.
His educational background is in Biochemistry, Chemistry and Clinical Laboratory Sciences. He has applied this knowledge in operational work experiences involving the development and deployment of novel medical diagnostic systems for the United States Air Force. Dr. Schoske has an extensive background in counter Chemical-Biological Consequence Management Planning. Prior to joining the DTRA, Dr. Schoske served in the United States Air Force for 21 years and is a retired Lieutenant Colonel. During his time on active duty he served in numerous capacities including Chief, of a Medical Laboratory, Assistant Professor of Chemistry at the United States Air Force Academy, Principal Investigator in Diagnostic R&D, and Emergency Medical Planning. He was selected as a Senior Air Force Laboratory Fellow for Science and Technology and is an American Society of Clinical Pathologists Certified Medical Technologist. He earned a Master’s of Arts in Biochemistry from the University of Scranton, and a PhD in Chemistry from American University in Washington DC
Dr. Scott Hartley is the CEO of Proengin Inc. which develops and manufactures chemical and biological detection systems. In this role, Dr. Hartley is responsible leading and directing Proengin operations in North American. Proengin is a leader in flame spectroscopy technology which is able to quickly and precisely identify key materials found in chemical warfare agents, precursor materials, binary agents, fourth generation agents as well as many toxic industrial chemicals. This technology is also able to identify key biological materials found in toxins, bacteria and spores. Proengin technology has been adopted for use in over 72 countries and is used for military, first responder, HAZMAT, chemical and security applications.
Prior to joining Proengin, Dr. Hartley was served in various Business Development roles for BAE Systems/Armor Holdings where he worked on personal protective equipment and combat vehicles. He also previously worked at Gentex Corporation where he held various engineering, program management and general management roles. Dr. Hartley holds BS degrees in Mechanical Engineering and Mathematics from Cedarville University, dual MBA’s in Finance and Operations Management from the University of Scranton, and a Doctorate of Management degree in Technology Systems Management from the University of Maryland. He holds 11 patents and serves on the Board of Directors for the Warrior Protection and Readiness Coalition.
From September 2012 to September 2019, he worked in the laboratory of the Organisation for the Prohibition of chemical Weapons (OPCW) – from July 2017 to September 2019 as the Head of Laboratory. His responsibilities, among others, included general guidance for all research activities, the conduct of the OPCW’s Proficiency Testing program, the lab’s quality system under ISO 17025 and ISO 17043, the initial planning phase of the new Center for Chemistry and Technology and in 2018 he was team leader for the OPCW’s missions to Salisbury and Amesbury following the poisoning of Sergej Skripal and his daughter Yulia.
From 2006 to 2010 he conducted contract R&D work in the area of CBRN defense. Main work was carried out at the Bundeswehr Institute of Pharmacology and Toxicology in Munich on the development of an enzymatic skin decontaminant. From 2010 to 2012 he was a Director’s Fellow at Los Alamos National Laboratory (NM, USA) continuing work on enzymes-based systems for CW detoxification.
Dr Blum holds a German master’s degree equivalent in chemistry from the Technical University of Braunschweig and a Ph.D. in biochemistry from the University of Frankfurt. The topic of his work was the nerve agent degrading enzyme DFPase from squid. In 2008 he finished an additional master’s degree (M.A.) in “War in the modern world” at the department of War Studies – King’s College London. Since 1 November 2020 Dr Blum is a Visiting Fellow at the Centre for Science and Security Studies (CSSS), Department of War Studies, King’s College, London and is now providing consultancy services the in the field of analysis, countermeasures, decontamination and mitigation of chemical warfare agents with more than 15 years of experience.
He holds the rank of Lieutenant Colonel in the Bundeswehr Reserve (NBC troops) and his current assignment is with the German DoD in the unit for arms control, disarmament and non-proliferation.
Dr. Cullin graduated with a Bachelor of Science degree in chemistry from the University of Pittsburgh in 1984. He proceeded to The Ohio State University and earned Masters (1988) and PH.D. (1991) degrees in Physical Chemistry.
Upon receiving his Ph.D., he took a position as a Research Chemist with the Naval Surface Warfare Center, Dahlgren Division (NSWCDD) in Dahlgren, VA. In 1996, he assumed duties as the NSWCDD Project Manager of the Air Base/Port Advanced Concept Technology Demonstration Program in support of the Joint Program Office for Biological Defense (JPO-BD).
In October 1998, he accepted a position with the Joint Program Office for Biological Defense (JPO-BD) as the Program Director for the Critical Reagents Program (CRP). From June 2002 until December of 2005, he was Director of Technology at the Joint Program Executive Office for Chemical and Biological Defense’s (JPEOCBD). His responsibilities were to be the JPEOCBD lead for the Transition of New Technologies into JPEOCBD advanced development and procurement programs, Horizontal Technology Integration, ACTD/ATD Generation and Coordination, Procurement of Non-Standard Equipment, JPEOCBD International Cooperation (Foreign Military Sales, Cooperative Development, Export License Requests), Intelligence and Threat Coordination and acquisition modeling and analysis.
In December 2005, he left federal service and moved to the private sector as the Senior Vice President for Technology Transition at ICx Technologies, where he was responsible for Detection group Agency interactions, Federal Government Program Development, product development road-mapping and integration of detection and surveillance products. ICx Technologies was acquired by FLIR systems in October 2010 and Dr. Cullin assumed the position as the Chief Technology Officer for FLIR Government Systems. From February 2014- March, 2020, Dr. Cullin assumed the position of the Vice President, R&D and Programs for FLIR Detection. He is currently the Vice President and General Manager of FLIR Detection Systems.
Dr Ronald Hann, Director Chemical/Biological Technologies Department (RDCB), Defense Threat Reduction Agency (DTRA) Dr. Ron Hann, a member of the Senior Executive Service (SES), is the Director, Chemical/Biological Technologies Department (RDCB) for the Defense Threat Reduction Agency (DTRA) located on Fort Belvoir,Va. DTRA safeguards America and its allies from weapons of mass destruction (chemical, biological, radiological, nuclear, and high explosives) by providing capabilities to reduce, eliminate, and counter the threat, along with mitigating its effects. Dr. Hann oversees a vibrant science and technology department that works with industry, research universities, other agencies within the Department of Defense and the U.S. government to research, develop and field revolutionary technologies that address the threats posed by chemical and biological weapons, materials, agents and emerging diseases to our warfighters. DTRA RDCB also serves as the Joint Science and Technology Office, a member of the Chemical and Biological Defense Program (CBDP).This office, established in 2003 by Congress, is tasked to develop, coordinate, integrate, execute, and transition DoD CB S&T medical and nonmedical programs in response to Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense requirements, the Joint Program Executive Office for Chemical Biological Defense programs, and Chemical and Biological Defense Program Test and Evaluation technology needs. Dr. Hann was promoted to the SES Corps in April 2014 following his retirement from the U.S.Army Chemical Corps after almost 27 years of active duty. His time in the Army included combat tours in Operation Desert Shield/Desert Storm and Operation Iraqi Freedom, an operational tour in Operation Joint Forge, Bosnia Herzegovina, and two academic teaching tours as an Assistant Professor of Chemistry at the U.S. Military Academy at West Point.
Dr. Eric L. Moore, SES-Tier 2/Director
Dr. Eric L. Moore is the Director, DEVCOM CBC (Combat Capabilities Development Command Chemical Biological Center), the primary Department of Defense (DoD) technical organization for non-medical chemical and biological defense. He is an expert in chemical and biological defense programs and medical counter-measures and is a former Army officer.
As the Director of DEVCOM CBC, Dr. Moore oversees many of the Nation’s key chemical and biological defense research and engineering projects, building partnerships across DoD, other government agencies, industry and academia to enhance warfighter readiness and response to chemical and biological threats. He previously served as the Chair and U.S. National Lead of the Chemical, Biological, and Radiological (CBR) Memorandum of Understanding (MOU) Assess and Inform Working Groups. As Chair, Dr. Moore led CBR MOU efforts between the United States, United Kingdom, Canada, and Australia to enable warfighters to detect, prevent, protect against and respond to global CBR threats.
Dr. Moore received several noteworthy honors including the 2019 Mid-Atlantic Federal Laboratory Consortium Laboratory Director of the Year Award; the DoD Distinguished Civilian Service Award, the department's highest award given to career DoD civilian employees whose careers reflect exceptional devotion to duty; the Harold D. West, Ph.D. Distinguished Biomedical Scientist Award from Meharry Medical College, which is given to alumni who have demonstrated merit in their area of expertise, and have also made significant and meaningful progress in the highest ethical principles of biomedical conduct.
He is a member of Phi Beta Sigma Fraternity Inc. Omicron Psi Sigma Chapter.
Dr. Philipp C. Bleek is Associate Professor in the Nonproliferation and Terrorism Studies Program, Coordinator of the Cyber Collaborative, and Fellow at the James Martin Center for Nonproliferation Studies, al. at the Middlebury Institute of International Studies at Monterey. His research and teaching focuses on the causes, consequences, and amelioration of chemical, biological, radiological, and nuclear weapons proliferation to both states and non-state actors.
Dr. Bleek previously served as Senior Advisor to the Assistant Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. He has held fellowship at Council on Foreign Relations, Harvard University’s Belfer Center, the Center for Strategic and International Studies, and the Center for New American Security, among others. He has also served as an advisor to several political campaigns, a consultant to the U.S. government and non-governmental organizations, and regularly participates in Track 2 dialogues. He is a former Emergency Medical Technician (New Jersey).
He recently co-authored, with Cyrus Jabbari, “Acid reign of terror” in CBRNe World (May 2020). This and other publications are available at his faculty page.
CEO, ITL Solutions
Bill Guglielmo is CEO of ITL Solutions, a Service Disabled Veteran Owned Small Business specializing in equipment design, sales, and service for US Government and Department of Defense. ITL Solutions features mission specific equipment to counter CBR threats such as the Modula S Ultra Efficient Anti-Microbial Ebola Treatment Unit using CuVerro® anti-microbial metals. ITL Solutions is proud to be the US Distributor of the Cristanini line of CBR Decontamination equipment.
Mr. Guglielmo served as an Officer in the US Navy as a member of the Surface Warfare and Civil Engineering Corps communities. His tours of duty include Navigator of USS GETTYSBURG (CG 64), staff in Expeditionary Strike Group FIVE, Security Force Assistance in the Maritime Civil Affairs and Security Training Command, Civil Affairs and Military Information Support Operations for Naval Special Warfare Unit 10, and as Task Group 56.2 Commander providing construction forces in support of Operation INHERENT RESOLVE to execute construction, engineering reconnaissance, and runway repairs. During USS GETTYSBURG’s 2009 deployment to the Middle East, Bill led the ship’s Visit, Board, Search, and Seizure (VBSS) Team capturing 38 suspected pirates and numerous suspected pirate vessels including one mothership.
Bill was also an Instructor at the US Navy Nuclear Power Training Unit in Charleston, South Carolina on board the Moored Training Ship 635 (ex-USS SAM RAYBURN). Mr. Guglielmo holds a Bachelor’s of Science degree in Mechanical Engineering from Lehigh University and a Master’s of Engineering Management from Old Dominion University.
Director, Massachusetts Department of Fire Services Hazardous Materials Emergency Response Division.
David DiGregorio serves as the Director, Massachusetts Department of Fire Services Hazardous Materials Emergency Response Division. He retired from the US Army and Massachusetts Army National Guard after 32 years of service in 2014. He has earned a MS degree in Emergency Management from the Massachusetts Maritime Academy, a BS degree and MS degree in Physician Assistant Studies from the University of Nebraska Medical Center. He serves as faculty for the Massachusetts Maritime Academy as a capstone advisor for the graduate level Emergency Management program.
Eric was appointed by the Government as the Commissioner of the Singapore Civil Defence Force (SCDF) in February 2012. In his 29 years of service, he helmed several key appointments such as the Senior Director of the Homefront Security Division of the Ministry of Home Affairs (MHA), SCDF’s Director of Operations, Division Commander and Fire Station Commander. Prior to his present appointment, he was the Senior Director of Emergency Services in SCDF between 2010 and 2011. That office oversaw all aspects of emergency services provision (i.e. firefighting, rescue, HazMat, and EMS) in Singapore.
Throughout his career, Eric led numerous operations involving collapsed structures rescue, major fires, large tank fires, and contingency response deployment for high-profile events involving international participants such as the Trump-Kim Singapore Summit in June 2018. As a leader, he led the transformation of SCDF into a modern, future-ready emergency response organisation that leverages people, partnerships, technology and innovation. As the national focal point for disaster management, Eric was the Chairperson of the ASEAN Committee on Disaster Management (ACDM) in 2021 and a member of the UN INSARAG Steering Committee and the UNDAC Advisory Board.
Eric graduated from the UK in 1993 with a BA degree (1st Class Hons) and in 2000, he was appointed as a Foreign Fellow under the US Fulbright Program and graduated with a MA degree from Emerson College, Boston, USA, in 2001. He is also a graduate of the Stanford Executive Program 2009, Graduate School of Business at Stanford University.
He was conferred the Republic’s State honours of the Public Administration Medal (Bronze) and (Silver) by the President in 2004 and 2012 respectively.
Ryan Gregerson holds a Master’s Degree in Biotechnology and a B.S. in Biology. He began working for BioFire Defense in 2012 and has had the opportunity to work in both technical and business roles. Ryan currently works as a Product Marketing Manager with some of the coolest biotechnology around.
BioFire Defense is a technology innovation and product development company that has been supplying solutions to field forces and laboratories for BioThreat detection and disease surveillance since 1990.